Skip to main content

All Access Subscription

Get unlimited access to our full publication and article library.

Get Access Now

Interested in Group Sales? Learn more

Articles Tagged With:

  • A Third Arrow in the Quiver: FDA Grants Emergency Use of New Vaccine

    The Food and Drug Administration has issued an emergency use authorization for a third vaccine COVID-19 in the United States, approving Janssen Biotech’s vaccine for administration to those 18 years and older.

  • The Long Tail of COVID-19

    There now is an open question about whether some people — healthcare workers and the public alike — could experience recurrent COVID-19 symptoms for years. This is the nightmarish world of the so-called “long-haulers,” who have developed a seemingly chronic condition the Centers for Disease and Control and Prevention is calling “long COVID.”

  • Staggering COVID-19 Mortality Rates During Pregnancy

    Pregnant women, some of them healthcare workers, are dying at high rates after contracting COVID-19. The COVID-19 vaccine risk is unknown because pregnant women were not included in early clinical trials. However, the emerging data on the threat of COVID-19 infection during pregnancy is tilting the risk-benefit equation.

  • No One Really Knows How Many HCWs Have Died of COVID-19

    While healthcare workers literally bear witness to death, who tolls the bell for them? There is no official count for healthcare workers who have died of COVID-19. Ask how many of these heroes have put their lives on the line and lost them in the process, and one enters a maze of incomplete reports collected from limited jurisdictions, mixed with extrapolations and models confounded with variables.

  • The Agitated Patient in the Emergency Department

    Agitation is a common presentation to the emergency department worldwide, as either the chief complaint or as a component of another medical problem. Agitation may be a manifestation of behavioral and mental health issues, have an organic medical or traumatic etiology, or be a result of substance abuse or withdrawal.

  • FDA, CDC Sign Off on Third COVID-19 Vaccine

    Johnson & Johnson’s COVID-19 vaccine is the first single-shot solution to receive an agency emergency use authorization.

  • The Basic Elements of Healthcare Reimbursement, Part 3

    In this month’s issue, the conversation on healthcare reimbursement turns to the additional prospective payment systems found across the continuum of care. Prospective payment remains a way in which the Centers for Medicare & Medicaid Services can determine the rates for care based on predetermined amounts rather than on billing. The processes are similar to the use of the diagnosis-related groups in the acute care setting, with some differences.

  • Leaders Plot How They Will Leverage the Lessons of COVID-19

    While healthcare leaders continue to battle a global pandemic, many also are plotting how they will use the lessons of this emergency to make their health systems better. Several shared their ideas during the Institute for Healthcare Improvement’s annual forum.

  • Opioid Use and the Role of the Case Manager

    Regardless of whether they know it, many case managers are faced with patients and clients each day who are struggling with opioid use disorder (OUD). As rates of OUD continue to increase, it is essential for case managers to hone their skills of confidently recognizing and addressing the disorder.

  • Using Trained Observers to Keep At-Risk Patients Safe

    A background as a personal care attendant, medical assistant, or mental health worker is a plus.